BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Events

APAC Fertility Experts Set New Gold Standard for Endometriosis Care and Fertility Preservation

Fertility specialists in the Asia Pacific region are bringing to fruition new standards of care for women and girls suffering from endometriosis and to hel...

May 01, 2025 | News

Abu Dhabi Leads Global Call for AI Governance in Healthcare at ADGHW Roundtable

Held during Abu Dhabi Global Health Week, the roundtable united global health leaders to shape a Declaration on AI governance principles for healthcare ...

April 25, 2025 | News

China Rises as Global Force in Blood Purification Tech at BPPC Annual Conference

Blood Purification Professional Committee (BPPC) of the China Medical Device Industry Association (CMDIA) gathered in Liuyang, Hunan, for its annual c...

April 21, 2025 | News

Middle East Takes Global Lead in Precision Medicine and Longevity Science with Landmark Abu Dhabi Declaration

Establishing actionable frameworks to advance precision medicine and longevity science The declaration highlights the impact longevity and precision med...

April 21, 2025 | News

ISFMS 2025 Set to Spotlight Molecular Mechanisms and Structure-Based Drug Discovery in Kyoto

The symposium will present outstanding research results that elucidate the molecular mechanisms of biological function and regulation, and ...

April 16, 2025 | News

Seegene to Introduce Vision for Fully Automated PCR Testing with CURECA™ at ESCMID Global 2025 in Vienna

- Seegene to showcase a conceptual video introducing CURECA™ at ESCMID Global 2025 — a full automation system expected ...

April 10, 2025 | News

Hyundai ADM Bio Penetrium Shows Strong Anti Metastatic Efficacy in TNBC Study

Hyundai ADM Bio (KOSDAQ symbol 187660) announced on the 24th that its first-in-class pseudo-resistance-targeting agent, PenetriumTM, showed significan...

March 28, 2025 | News

Akeso Showcases Positive Phase III Safety Run-In Data for Cadonilimab at SGO 2025 in Locally Advanced Cervical Cancer

Akeso Inc. (9926.HK) presented promising phase III safety run-in results from the COMPASSION-18/AK104-305 study, at the 2025 Annual Meeting of the Society ...

March 24, 2025 | Report

VantAI Introduces Neo-1, the First Unified Model for De Novo Molecular Generation and Structure Prediction

Neo-1 is the first model to unify de novo molecular generation and atomic-level structure prediction in a single model, by generating latent representa...

March 24, 2025 | News

Dizal to Present New Findings on Golidocitinib-PD-1 Combo and Sunvozertinib-Anlotinib Therapy at ELCC 2025

Dizal (SSE: 688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced ...

March 21, 2025 | News

TPIsoftware & Yuan's General Hospital Transform Healthcare with GenAI Platform

TPIsoftware (TWSE: 7781) and Yuan's General Hospital, a leading medical institution in Southern Taiwan, have collaborated to launch a digit...

March 20, 2025 | News

Navigating Biologics Development: Strategies for Regulatory Success, CMC Challenges, and Tech Transfer

Click here to Register Now! As the biologics field rapidly evolves, mastering regulatory pathways, process development, and tech transfer is essential for...

March 12, 2025 | News

Daiichi Sankyo and AstraZeneca’s ENHERTU Recommended for EU Approval for HER2 Low and HER2 Ultralow Metastatic Breast Cancer

Daiichi Sankyo (TSE: 4568) and AstraZeneca’s (LSE/STO/Nasdaq: AZN) ENHERTU® (trastuzumab deruxtecan) has been recommended for approval in th...

March 03, 2025 | News

Webinar from ProBio: Multiple Solutions of Antibody Discovery and Engineering

Click here to Register Now! Topic 1: Solution of functional lead discovery via integrated antibody generation platform The screening funnel of therapeu...

February 20, 2025 | News

Stay Connected